uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cathelicidins positively regulate pancreatic beta-cell functions
Jiangnan Univ, Ctr Food Safety & Nutr, Sch Food Sci & Technol & Synerget Innovat, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China..
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC.
Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, Stockholm, Sweden..
Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden..
Show others and affiliations
2016 (English)In: The FASEB Journal, ISSN 0892-6638, E-ISSN 1530-6860, Vol. 30, no 2, 884-894 p.Article in journal (Refereed) PublishedText
Abstract [en]

Cathelicidins are pleiotropic antimicrobial peptides largely described for innate antimicrobial defenses and, more recently, immunomodulation. They are shown to modulate a variety of immune or nonimmune host cell responses. However, how cathelicidins are expressed by beta cells and modulate beta-cell functions under steady-state or proinflammatory conditions are unknown. We find that cathelicidin-related antimicrobial peptide (CRAMP) is constitutively expressed by rat insulinoma b-cell clone INS-1 832/13. CRAMP expression is inducible by butyrate or phenylbutyric acid and its secretion triggered upon inflammatory challenges by IL-1 beta or LPS. CRAMP promotes b-cell survival in vitro via the epidermal growth factor receptor (EGFR) and by modulating expression of antiapoptotic Bcl-2 family proteins: p-Bad, Bcl-2, and Bcl-xL. Also via EGFR, CRAMP stimulates glucose-stimulated insulin secretion ex vivo by rat islets. A similar effect is observed in diabetes-prone nonobese diabetic (NOD) mice. Additional investigation under inflammatory conditions reveals that CRAMP modulates inflammatory responses and beta-cell apoptosis, asmeasured by prostaglandin E2 production, cyclooxygenases (COXs), and caspase activation. Finally, CRAMP-deficient cnlp(-/-) mice exhibit defective insulin secretion, and administration of CRAMP to prediabetic NOD mice improves blood glucose clearance upon glucose challenge. Our finding suggests that cathelicidins positively regulate beta-cell functions and may be potentially used for intervening b-cell dysfunction-associated diseases.

Place, publisher, year, edition, pages
2016. Vol. 30, no 2, 884-894 p.
Keyword [en]
antimicrobial peptide, CRAMP, immunomodulation, endocrine cells, type 1 diabetes
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
URN: urn:nbn:se:uu:diva-281975DOI: 10.1096/fj.15-275826ISI: 000369391900036PubMedID: 26527065OAI: oai:DiVA.org:uu-281975DiVA: diva2:916205
Swedish Research Council, 20854Swedish Research Council, 10350Swedish Research Council, K2014-67X-11217-20-3Swedish Foundation for Strategic Research , RBd08-0014

De två sista författarna delar sistaförfattarskapet.

Available from: 2016-04-01 Created: 2016-04-01 Last updated: 2016-04-01Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Chemistry - BMC
In the same journal
The FASEB Journal
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 47 hits
ReferencesLink to record
Permanent link

Direct link